Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women

Journal of Clinical Psychopharmacology

Volumn 31, Issue 1, 2011, Pages 56-60

  Bolton, James M ^a   Targownik, Laura E ^a   Leung, Stella ^a   Sareen, Jitender ^a   Leslie, William D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

antidepressants; bone mineral density; osteoporosis; psychotropic medication; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; MOOD STABILIZER; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; BONE DENSITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DRUG DEPENDENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; OSTEOPOROSIS; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; BONE DENSITY; DATABASES, FACTUAL; FEMALE; HUMANS; MENTAL DISORDERS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PSYCHOTROPIC DRUGS;

EID: 78651295833     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182075587     Document Type: Article

References (32)

1. Misra M, Papakostas GI, Klibanski A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry. 2004;65:1607-1618.
2. Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Curr Drug Saf. 2008;3:185-189.
3. Bolton JM, Metge C, Lix L, et al. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol. 2008;28:384-391.
4. Vestergaard P. Fracture risks of antidepressants. Expert Rev Neurother. 2009;9:137-141.
5. Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry. 2007;190:129-134.
6. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163:949-957.
7. Mezuk B, Eaton WW, Golden SH, et al. Depression, antidepressants, and bone mineral density in a population-based cohort. J Gerontol A Biol Sci Med Sci. 2008;63:1410-1415.
8. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188-194.
9. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007;167:1246-1251.
10. Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med. 2007;167:1240-1245.
11. Williams LJ, Henry MJ, Berk M, et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol. 2008;23:84-87.
12. Kinjo M, Setoguchi S, Schneeweiss S, et al. Bone mineral density in subjects using central nervous systemYactive medications. Am J Med. 2005;118:1414.
13. Spangler L, Scholes D, Brunner RL, et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med. 2008;23:567-574.
14. Plenge P, Rafaelsen OJ. Lithium effects on calcium, magnesium and phosphate in man: effects on balance, bone mineral content, faecal and urinary excretion. Acta Psychiatr Scand. 1982;66:361-373.
15. Cohen O, Rais T, Lepkifker E, et al. Lithium carbonate therapy is not a risk factor for osteoporosis. Horm Metab Res. 1998;30:594-597.
16. Zamani A, Omrani GR, Nasab MN. Lithium's effect on bone mineral density. Bone. 2009;44:331-334.
17. Liu-Seifert H, Kinon BJ, Ahl J. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann NY Acad Sci. 2004;1032: 297-298.
18. Hummer M, Malik P, Gasser RW. Osteoporosis in patients with schizophrenia. Am J Psychiatry. 2005;162:162-167.
19. Kishimoto T, Watanabe K, Shimada N, et al. Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia. J Clin Psychiatry. 2008;69:385-391.
20. Leslie WD, Caetano PA, Macwilliam LR, et al. Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005;8:25-30.
21. Lesie WD, Metge CJ. Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom. 2003;6: 275-282.
22. Leslie WD, MacWilliam L, Lix L, et al. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int. 2005;16:773-782.
23. Leslie WD, Caetano PA, Roe EB. The impact of hip subregion reference data on osteoporosis diagnosis. Osteoporos Int. 2005;16:1669-1674.
24. Frohlich N, Mustard C. A regional comparison of socioeconomic and health indices in a Canadian province. Soc Sci Med. 1996;42: 1273-1281.
25. Starfield B, Weiner J, Mumford L, et al. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26:53-74.
26. Leslie WD, Derksen S, Prior HJ, et al. The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian aboriginals and non-aboriginals. Osteoporos Int. 2006;17:1358-1368.
27. Bilici M, Cakirbay H, Guler M, et al. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int J Neurosci. 2002;112:817-828.
28. Meyer JM, Lehman D. Bone mineral density in male schizophrenia patients: a review. Ann Clin Psychiatry. 2006;18:43-48.
29. Halbreich U. Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation. CNS Drugs. 2007;21:641-657.
30. Robinson JR, Young TK, Roos LL, et al. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care. 1997;35:932-947.
31. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107-1115.
32. Osborn DP, Nazareth I, King MB. Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care. Soc Psychiatry Psychiatr Epidemiol. 2007;42:787-793.